Eva M. Villarón

1.6k total citations
23 papers, 1.1k citations indexed

About

Eva M. Villarón is a scholar working on Genetics, Hematology and Surgery. According to data from OpenAlex, Eva M. Villarón has authored 23 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Genetics, 12 papers in Hematology and 7 papers in Surgery. Recurrent topics in Eva M. Villarón's work include Mesenchymal stem cell research (10 papers), Hematopoietic Stem Cell Transplantation (9 papers) and Acute Myeloid Leukemia Research (7 papers). Eva M. Villarón is often cited by papers focused on Mesenchymal stem cell research (10 papers), Hematopoietic Stem Cell Transplantation (9 papers) and Acute Myeloid Leukemia Research (7 papers). Eva M. Villarón collaborates with scholars based in Spain. Eva M. Villarón's co-authors include Fermín Sánchez‐Guijo, Jesús F. San Miguel, Natalia López-Holgado, M.C. del Cañizo, Juan F. Blanco, Josè Antonio Pérez-Simón, María Díez‐Campelo, Felipe Prósper, Enrique J. Andreu and Olga López‐Villar and has published in prestigious journals such as Blood, Frontiers in Immunology and Leukemia.

In The Last Decade

Eva M. Villarón

23 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Eva M. Villarón Spain	13	597	364	240	232	211	23	1.1k
M.C. del Cañizo Spain	19	723 1.2×	632 1.7×	228 0.9×	254 1.1×	250 1.2×	51	1.4k
RE Gay Switzerland	7	582 1.0×	292 0.8×	224 0.9×	212 0.9×	156 0.7×	17	973
Joan García‐López Spain	14	337 0.6×	510 1.4×	167 0.7×	259 1.1×	104 0.5×	20	1.1k
Jehan J. El‐Jawhari United Kingdom	18	362 0.6×	123 0.3×	183 0.8×	269 1.2×	237 1.1×	38	1.1k
Soraya Carrancio Spain	15	380 0.6×	386 1.1×	175 0.7×	298 1.3×	64 0.3×	33	1.0k
María L. Lamana Spain	15	863 1.4×	345 0.9×	410 1.7×	383 1.7×	62 0.3×	27	1.4k
Katarina LeBlanc Sweden	16	1.0k 1.7×	339 0.9×	471 2.0×	380 1.6×	73 0.3×	21	1.6k
Sarah M. Churchman United Kingdom	21	511 0.9×	265 0.7×	370 1.5×	479 2.1×	581 2.8×	36	1.6k
Attila Szakos Sweden	11	1.0k 1.8×	357 1.0×	515 2.1×	353 1.5×	57 0.3×	20	1.6k
Ioannis Batsis Greece	16	627 1.1×	325 0.9×	349 1.5×	320 1.4×	68 0.3×	53	1.4k

Countries citing papers authored by Eva M. Villarón

Since Specialization

Citations

This map shows the geographic impact of Eva M. Villarón's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eva M. Villarón with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eva M. Villarón more than expected).

Fields of papers citing papers by Eva M. Villarón

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eva M. Villarón. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eva M. Villarón. The network helps show where Eva M. Villarón may publish in the future.

Co-authorship network of co-authors of Eva M. Villarón

This figure shows the co-authorship network connecting the top 25 collaborators of Eva M. Villarón. A scholar is included among the top collaborators of Eva M. Villarón based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eva M. Villarón. Eva M. Villarón is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

López-Parra, Miriam, Eva M. Villarón, María Díez‐Campelo, et al.. (2024). Treatment of post-allogeneic hematopoietic stem cell transplant cytopenias with sequential doses of multipotent mesenchymal stromal/stem cells. Cytotherapy. 26(8). 806–812. 1 indexed citations

Blanco, Juan F., Francisco J. García‐García, Eva M. Villarón, et al.. (2023). Long-Term Results of a Phase I/II Clinical Trial of Autologous Mesenchymal Stem Cell Therapy for Femoral Head Osteonecrosis. Journal of Clinical Medicine. 12(6). 2117–2117. 5 indexed citations

Jiménez, Marcelo F., María Teresa Gómez-Hernández, Eva M. Villarón, Miriam López-Parra, & Fermín Sánchez‐Guijo. (2023). Autologous mesenchymal stromal cells embedded with Tissucol Duo® for prevention of air leak after anatomical lung resection: results of a prospective phase I/II clinical trial with long-term follow-up. Stem Cell Research & Therapy. 14(1). 313–313. 2 indexed citations

Fernández‐Santos, María Eugenia, Enrique J. Andreu, Miriam López-Parra, et al.. (2022). Optimization of Mesenchymal Stromal Cell (MSC) Manufacturing Processes for a Better Therapeutic Outcome. Frontiers in Immunology. 13. 918565–918565. 79 indexed citations

Campo, Arantza, Enrique J. Andreu, Ana B. Alcaide, et al.. (2021). Endobronchial autologous bone marrow–mesenchymal stromal cells in idiopathic pulmonary fibrosis: a phase I trial. ERJ Open Research. 7(2). 773–2020. 20 indexed citations

Blanco, Juan F., Eva M. Villarón, David Pescador, et al.. (2019). Autologous mesenchymal stromal cells embedded in tricalcium phosphate for posterolateral spinal fusion: results of a prospective phase I/II clinical trial with long-term follow-up. Stem Cell Research & Therapy. 10(1). 63–63. 47 indexed citations

Martin-Rufino, Jorge D., et al.. (2018). Sequential intravenous allogeneic mesenchymal stromal cells as a potential treatment for thromboangiitis obliterans (Buerger’s disease). Stem Cell Research & Therapy. 9(1). 150–150. 12 indexed citations

Lamo-Espinosa, José María, Gonzalo Mora, Juan F. Blanco, et al.. (2016). Intra-articular injection of two different doses of autologous bone marrow mesenchymal stem cells versus hyaluronic acid in the treatment of knee osteoarthritis: multicenter randomized controlled clinical trial (phase I/II). Journal of Translational Medicine. 14(1). 246–246. 244 indexed citations

Muntión, Sandra, Fermín Sánchez‐Guijo, Soraya Carrancio, et al.. (2012). Optimisation of mesenchymal stromal cells karyotyping analysis: implications for clinical use. Transfusion Medicine. 22(2). 122–127. 12 indexed citations

10.

Sánchez‐Guijo, Fermín, Olga López‐Villar, Lucía López‐Anglada, et al.. (2011). Allogeneic mesenchymal stem cell therapy for refractory cytopenias after hematopoietic stem cell transplantation. Transfusion. 52(5). 1086–1091. 17 indexed citations

11.

López‐Villar, Olga, Juan Luis Garcı́a, Fermín Sánchez‐Guijo, et al.. (2009). Both expanded and uncultured mesenchymal stem cells from MDS patients are genomically abnormal, showing a specific genetic profile for the 5q− syndrome. Leukemia. 23(4). 664–672. 108 indexed citations

12.

López-Holgado, Natalia, Mercedes Alberca, Fermín Sánchez‐Guijo, et al.. (2009). Prospective comparative analysis of the angiogenic capacity of monocytes and CD133+ cells in a murine model of hind limb ischemia. Cytotherapy. 11(8). 1041–1051. 7 indexed citations

13.

Carrancio, Soraya, Natalia López-Holgado, Fermín Sánchez‐Guijo, et al.. (2008). Optimization of mesenchymal stem cell expansion procedures by cell separation and culture conditions modification. Experimental Hematology. 36(8). 1014–1021. 133 indexed citations

14.

Villarón, Eva M., Júlia Almeida, Natalia López-Holgado, et al.. (2007). In leukapheresis products from non-Hodgkin’s lymphoma patients, the immature hematopoietic progenitors show higher CD90 and CD34 antigenic expression. Transfusion and Apheresis Science. 37(2). 145–156. 5 indexed citations

15.

Sánchez‐Guijo, Fermín, et al.. (2007). P021 Cytogenetic characterization by array comparative genomic hybridization and fluorescence in situ hybridization of mesenchymal stem cells from patients with myelodysplastic syndromes. Leukemia Research. 31. S52–S52. 2 indexed citations

16.

López-Holgado, Natalia, Mercedes Alberca, Fermín Sánchez‐Guijo, et al.. (2006). Short-term endothelial progenitor cell colonies are composed of monocytes and do not acquire endothelial markers. Cytotherapy. 9(1). 14–22. 23 indexed citations

17.

Sánchez‐Guijo, Fermín, Eva M. Villarón, Natalia López-Holgado, et al.. (2005). Posttransplant hematopoiesis in patients undergoing sibling allogeneic stem cell transplantation reflects that of their respective donors although with a lower functional capability. Experimental Hematology. 33(8). 935–943. 8 indexed citations

18.

Sánchez‐Guijo, Fermín, Clara Bueno, Eva M. Villarón, et al.. (2005). Long-term Immune Recovery of Patients Undergoing Allogeneic Stem Cell Transplantation: A Comparison with Their Respective Sibling Donors. Biology of Blood and Marrow Transplantation. 11(5). 354–361. 12 indexed citations

19.

López-Holgado, Natalia, José Luis Arroyo, Eva M. Villarón, et al.. (2004). Analysis of hematopoietic progenitor cells in patients with myelodysplastic syndromes according to their cytogenetic abnormalities. Leukemia Research. 28(11). 1181–1187. 6 indexed citations

20.

Cañizo, MC, María Eugenia Fernández‐Santos, Antonio López, et al.. (2003). Immunophenotypic analysis of myelodysplastic syndromes.. PubMed. 88(4). 402–7. 45 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact